Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection
Explore this paper's citation graph
- Type
- article
- Published
- 2003-01-01
- Cited by
- 6,030
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W2394597245
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:57276474
Keywords
Ribavirin, Medicine, Virology, Chronic hepatitis, Peginterferon alfa-2a
References
No references recorded for this paper.
Cited by
- Particularités de l'infection VHC et de la thérapeutique anti-VHC chez les patients co-infectés VIH/VHC
- CHRONIC HEPATITIS FROM A PSYCHIATRIC POINT OF VIEW
- Resistance of Hepatitis C Virus to Ns3–4A Protease Inhibitors: Mechanisms of Drug Resistance Induced by R155Q, A156T, D168A and D168V Mutations
- Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin.
- Chronische Hepatitiden bei Kindern und Jugendlichen
- Complementary and alternative medications in hepatitis C infection.
- Triple therapy with amantadine in treatment‐naive patients with chronic hepatitis C: A placebo‐controlled trial
- Dinucleotide Analogues as Novel Inhibitors of RNA-Dependent RNA Polymerase of Hepatitis C Virus
- Diagnostic Testing in Hepatitis C Virus Infection: Viral Kinetics and Genomics
- Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy
- Protein-dynamics of the putative HCV receptor CD81 large extracellular loop.
- Treatment of chronic hepatitis C in HIV/HCV‐coinfection with interferon α‐2b+ full‐course vs. 16‐week delayed ribavirin
- Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice.
- Treatment of relapsers after combination therapy for chronic hepatitis C.
- Serum Levels of Hepatitis C Virus Core Antigen as a Marker of Infection and Response to Therapy
- Genetic manipulations utilizing albumin and alpha‐fetoprotein promoter/enhancers affect both hepatocytes and oval cells
- The phenomenology and treatment of interferon-induced depression.
- Early viral kinetics and treatment outcome in combination of high‐dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load
- Hematologic side effects of interferon and ribavirin therapy.
- Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.
Related papers
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.
- Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
- PEGINTERFERON ALFA-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C VIRUS INFECTION
- Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection in the community-based practive
- 782 CHRONIC HEPATITIS C GENOTYPE 4: EFFICACY AND SAFETY OF THE TREATMENT WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN
- Taribavirin vs. Ribavirin for Chronic Hepatitis C Virus Infection
- Peginterferon-alpha-2a and ribavirin combination therapy in chronic hepatitis C infection